In support of a potential involvement of GSDMB in the development of multiple sclerosis (MS), it was demonstrated that reducing the expression of GSDMB in memory CD4+ T-cells resulted in an increased production of cytokines, including tumour necrosis factor (TNF), interleukin (IL)-13, and IL-16 [130]. This evidence concerns the gene CD4 and myeloid sarcoma.